Condition

Sentinel Lymph Node Biopsy

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 18 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials18
Recruiting2
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

18 shown
No Axillary Surgical Treatment in Clinically Lymph Node Negative Patients on Ultrasonography After Neoadjuvant ChemotherapyNCT06704945 · 2025-06-04
RECRUITING
Axillary Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With Initial cN1 Breast CancerNCT06518135 · 2024-04-30
RECRUITING
NAUTILUS-04: No Axillary Surgical Treatment in Low-Risk Clinically Node-Negative Breast Cancer Without Whole-Breast Radiotherapy - A Prospective, Randomized, Phase III, Non-inferiority Clinical TrialNCT07841704 · 2026-10-01
NOT_YET_RECRUITING
Does Ultrasound Guidance Axillary Incision Improve Sentinel Lymph Node Detection in Breast Cancer?NCT07338721 · 2026-01-01
COMPLETED
Hemodynamic Effects of Intradermal Methylene Blue During Breast Surgery Under General AnesthesiaNCT07040540 · 2025-07-01
COMPLETED
Comparing the QoR of PECS Block and GA in Breast-conserving Surgery With Sentinel Lymph Node BiopsyNCT06120439 · 2023-12-01
COMPLETED
Oncologic Safety of Sentinel Lymph Node Biopsy in Clinically Palpable Axillary Lymph Node in Breast Cancer PatientsNCT05703295 · 2023-02-01
UNKNOWN
A Study to Find the Best Dose of ASP5354 to Show Lymph Nodes in People With Breast Cancer or Melanoma During SurgeryNCT05457842 · 2022-08-10
TERMINATED
Contrast-enhanced Ultrasonography Combined With Blue Dye as Dual-tracer for Sentinel Lymph Node BiopsyNCT04932460 · 2021-06-15
UNKNOWN
The Validation of Sentinel Lymph Node Biopsy After Neo-adjuvant Chemotherapy in Breast Cancer PatientsNCT04986306 · 2021-05-20
UNKNOWN
Clinical Application of Multi-modal Sentinel Lymph Node Staining Method in Breast Cancer Patients After Neoadjuvant ChemotherapyNCT06212440 · 2021-05-04
COMPLETED
Application of Preoperative Axillary Lymph Node Marking With Nano-Carbon in Breast Cancer Patients Before Neoadjuvant ChemotherapyNCT05512468 · 2020-03-01
UNKNOWN
A Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems (SPY-PHI) in the Visualization of Lymphatic Vessels and Identification of Lymph Nodes During Sentinel Lymph Node Biopsy in Subjects With Breast CancerNCT03200704 · 2019-01-04
COMPLETED
Sentinel Lymph Node Biopsy After Neoadjuvant Treatment in Breast Cancer PatentsNCT03719833 · 2018-09-21
COMPLETED
Sentinel Lymph Node Procedure in Ipsilateral Invasive Breast Cancer RelapseNCT03630653 · 2018-05-29
TERMINATED
Tilmanocept vs Sulfur Colloid in Sentinel Lymph Node BiopsyNCT03199560 · 2017-06-22
UNKNOWN
SLNB After Neoadjuvant Treatment in Node Positive PatientsNCT03833960 · 2016-05-01
COMPLETED
Intraoperative Molecular Diagnosis of Sentinel Lymph Node In Breast Cancer PatientsNCT03937414 · 2010-02-01
UNKNOWN

Common interventions

Leading sponsors

Trial status mix

COMPLETED7
UNKNOWN6
RECRUITING2
TERMINATED2
NOT_YET_RECRUITING1

Phase mix

NA7
PHASE32
PHASE21
PHASE41
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.